SELLAS Life Sciences Group Ownership 2024 | Who Owns SELLAS Life Sciences Group Now?
Institutional Ownership
9.05%
Insider Ownership
0.24%
Retail Ownership
90.70%
Institutional Holders
35.00
SELLAS Life Sciences Group Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 3.99% | - | 1,786,334 | 273,099 | 18.05% | 2,125,737 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 3.30% | 0.01% | 1,479,067 | 479,067 | 47.91% | 1,760,090 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.15% | 0.00% | 517,008 | 243,945 | 89.34% | 615,329 | Jun 30, 2024 |
| BLACKROCK INC. | 0.96% | - | 430,368 | 152,150 | 54.69% | 512,138 | Jun 30, 2024 |
| OPUS CAPITAL GROUP, LLC | 0.49% | 0.04% | 221,000 | 20,400 | 10.17% | 263,000 | Jun 30, 2024 |
| EQUITABLE HOLDINGS, INC. | 0.47% | 0.00% | 210,000 | 10,000 | 5.00% | 249,900 | Jun 30, 2024 |
| DIAMETRIC CAPITAL, LP | 0.34% | 0.10% | 153,019 | 153,019 | 100.00% | 182,092 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.34% | 0.00% | 150,448 | 150,448 | 100.00% | 179,033 | Jun 30, 2024 |
| STATE STREET CORP | 0.30% | - | 134,029 | 36,900 | 37.99% | 159,495,000 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.23% | - | 100,843 | 12,113 | 13.65% | 120,004,000 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.14% | 0.01% | 63,843 | 24,414 | 61.92% | 76,000 | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.12% | 0.00% | 55,726 | 55,726 | 100.00% | 66,314 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.12% | - | 51,894 | 51,894 | 100.00% | 61,754 | Jun 30, 2024 |
| MARINER, LLC | 0.10% | 0.00% | 44,929 | 19,672 | 77.89% | 53,466 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.07% | 0.00% | 32,446 | 32,446 | 100.00% | 38,611 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.04% | - | 16,238 | - | - | 19,323 | Jun 30, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.03% | - | 15,554 | 1,500 | 10.67% | 19,000 | Jun 30, 2024 |
| WEDBUSH SECURITIES INC | 0.03% | 0.00% | 15,000 | 15,000 | 100.00% | 18,000 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 13,631 | -7,094 | -34.23% | 16,221 | Jun 30, 2024 |
| BELVEDERE TRADING LLC | 0.03% | - | 12,700 | 12,700 | 100.00% | 15,113 | Jun 30, 2024 |
SELLAS Life Sciences Group's largest institutional shareholder is VANGUARD GROUP INC, holding 3.99% of the company's total share outstanding, currently valued at $2.13M. The top 10 institutional shareholders own together 11.56% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DIAMETRIC CAPITAL, LP | 0.34% | 0.10% | 153,019 | 153,019 | 100.00% | 182,092 | Jun 30, 2024 |
| OPUS CAPITAL GROUP, LLC | 0.49% | 0.04% | 221,000 | 20,400 | 10.17% | 263,000 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 3.30% | 0.01% | 1,479,067 | 479,067 | 47.91% | 1,760,090 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.14% | 0.01% | 63,843 | 24,414 | 61.92% | 76,000 | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.12% | 0.00% | 55,726 | 55,726 | 100.00% | 66,314 | Jun 30, 2024 |
| EQUITABLE HOLDINGS, INC. | 0.47% | 0.00% | 210,000 | 10,000 | 5.00% | 249,900 | Jun 30, 2024 |
| NEMES RUSH GROUP LLC | 0.02% | 0.00% | 10,000 | - | - | 11,900 | Jun 30, 2024 |
| WEDBUSH SECURITIES INC | 0.03% | 0.00% | 15,000 | 15,000 | 100.00% | 18,000 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 13,631 | -7,094 | -34.23% | 16,221 | Jun 30, 2024 |
| MARINER, LLC | 0.10% | 0.00% | 44,929 | 19,672 | 77.89% | 53,466 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.34% | 0.00% | 150,448 | 150,448 | 100.00% | 179,033 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.07% | 0.00% | 32,446 | 32,446 | 100.00% | 38,611 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.15% | 0.00% | 517,008 | 243,945 | 89.34% | 615,329 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.99% | - | 1,786,334 | 273,099 | 18.05% | 2,125,737 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.12% | - | 51,894 | 51,894 | 100.00% | 61,754 | Jun 30, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.03% | - | 15,554 | 1,500 | 10.67% | 19,000 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.23% | - | 100,843 | 12,113 | 13.65% | 120,004,000 | Jun 30, 2024 |
| BELVEDERE TRADING LLC | 0.03% | - | 12,700 | 12,700 | 100.00% | 15,113 | Jun 30, 2024 |
| BLACKROCK INC. | 0.96% | - | 430,368 | 152,150 | 54.69% | 512,138 | Jun 30, 2024 |
| STATE STREET CORP | 0.30% | - | 134,029 | 36,900 | 37.99% | 159,495,000 | Jun 30, 2024 |
The largest SELLAS Life Sciences Group shareholder by % of total assets is DIAMETRIC CAPITAL, LP. The company owns 153.02K shares of SELLAS Life Sciences Group (SLS), representing 0.10% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALYESKA INVESTMENT GROUP, L.P. | 3.30% | 0.01% | 1,479,067 | 479,067 | 47.91% | 1,760,090 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.99% | - | 1,786,334 | 273,099 | 18.05% | 2,125,737 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.15% | 0.00% | 517,008 | 243,945 | 89.34% | 615,329 | Jun 30, 2024 |
| DIAMETRIC CAPITAL, LP | 0.34% | 0.10% | 153,019 | 153,019 | 100.00% | 182,092 | Jun 30, 2024 |
| BLACKROCK INC. | 0.96% | - | 430,368 | 152,150 | 54.69% | 512,138 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.34% | 0.00% | 150,448 | 150,448 | 100.00% | 179,033 | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.12% | 0.00% | 55,726 | 55,726 | 100.00% | 66,314 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.12% | - | 51,894 | 51,894 | 100.00% | 61,754 | Jun 30, 2024 |
| STATE STREET CORP | 0.30% | - | 134,029 | 36,900 | 37.99% | 159,495,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.07% | 0.00% | 32,446 | 32,446 | 100.00% | 38,611 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.14% | 0.01% | 63,843 | 24,414 | 61.92% | 76,000 | Jun 30, 2024 |
| OPUS CAPITAL GROUP, LLC | 0.49% | 0.04% | 221,000 | 20,400 | 10.17% | 263,000 | Jun 30, 2024 |
| MARINER, LLC | 0.10% | 0.00% | 44,929 | 19,672 | 77.89% | 53,466 | Jun 30, 2024 |
| WEDBUSH SECURITIES INC | 0.03% | 0.00% | 15,000 | 15,000 | 100.00% | 18,000 | Jun 30, 2024 |
| BELVEDERE TRADING LLC | 0.03% | - | 12,700 | 12,700 | 100.00% | 15,113 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.23% | - | 100,843 | 12,113 | 13.65% | 120,004,000 | Jun 30, 2024 |
| EQUITABLE HOLDINGS, INC. | 0.47% | 0.00% | 210,000 | 10,000 | 5.00% | 249,900 | Jun 30, 2024 |
| MORGAN STANLEY | 0.01% | - | 3,297 | 1,877 | 132.18% | 3,923 | Jun 30, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.03% | - | 15,554 | 1,500 | 10.67% | 19,000 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.00% | - | 669 | 669 | 100.00% | 1,000 | Jun 30, 2024 |
As of Jun 30 2024, SELLAS Life Sciences Group's largest institutional buyer is ALYESKA INVESTMENT GROUP, L.P.. The company purchased 479.07K stocks of SLS, valued at $1.76M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ANSON FUNDS MANAGEMENT LP | - | - | - | -4,832,368 | -100.00% | - | Jun 30, 2024 |
| PROSPERITY FINANCIAL GROUP, INC. | - | - | - | -25,385 | -100.00% | - | Jun 30, 2024 |
| CANTOR FITZGERALD, L. P. | - | - | - | -24,750 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -17,391 | -100.00% | - | Jun 30, 2024 |
| BROOKLYN FI, LLC | - | - | - | -11,178 | -100.00% | - | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 13,631 | -7,094 | -34.23% | 16,221 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -6,092 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -301 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | - | - | - | -1 | -100.00% | - | Jun 30, 2024 |
| NEMES RUSH GROUP LLC | 0.02% | 0.00% | 10,000 | - | - | 11,900 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 1,660 | - | - | 1,975 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.04% | - | 16,238 | - | - | 19,323 | Jun 30, 2024 |
| JANICZEK WEALTH MANAGEMENT, LLC | - | - | 11 | - | - | 14 | Jun 30, 2024 |
| ALLWORTH FINANCIAL LP | 0.00% | - | 150 | - | - | 167 | Jun 30, 2024 |
| PARKSIDE FINANCIAL BANK & TRUST | - | - | 2 | - | - | 3 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | 2 | - | - | 2 | Jun 30, 2024 |
| JONES FINANCIAL COMPANIES LLLP | 0.00% | - | 374 | 374 | 100.00% | 445 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 577 | 577 | 100.00% | 687 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.00% | - | 669 | 669 | 100.00% | 1,000 | Jun 30, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.03% | - | 15,554 | 1,500 | 10.67% | 19,000 | Jun 30, 2024 |
As of Jun 30 2024, SELLAS Life Sciences Group's biggest institutional seller is ANSON FUNDS MANAGEMENT LP. The company sold -4.83M shares of SLS, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DIAMETRIC CAPITAL, LP | 0.34% | 0.10% | 153,019 | 153,019 | 100.00% | 182,092 | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.12% | 0.00% | 55,726 | 55,726 | 100.00% | 66,314 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.12% | - | 51,894 | 51,894 | 100.00% | 61,754 | Jun 30, 2024 |
| WEDBUSH SECURITIES INC | 0.03% | 0.00% | 15,000 | 15,000 | 100.00% | 18,000 | Jun 30, 2024 |
| BELVEDERE TRADING LLC | 0.03% | - | 12,700 | 12,700 | 100.00% | 15,113 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.00% | - | 669 | 669 | 100.00% | 1,000 | Jun 30, 2024 |
| JONES FINANCIAL COMPANIES LLLP | 0.00% | - | 374 | 374 | 100.00% | 445 | Jun 30, 2024 |
SELLAS Life Sciences Group's largest new institutional shareholder by number of shares is DIAMETRIC CAPITAL, LP, purchased 153.02K shares, valued at $182.09K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ANSON FUNDS MANAGEMENT LP | - | - | - | -4,832,368 | -100.00% | - | Jun 30, 2024 |
| PROSPERITY FINANCIAL GROUP, INC. | - | - | - | -25,385 | -100.00% | - | Jun 30, 2024 |
| CANTOR FITZGERALD, L. P. | - | - | - | -24,750 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -17,391 | -100.00% | - | Jun 30, 2024 |
| BROOKLYN FI, LLC | - | - | - | -11,178 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -6,092 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -301 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | - | - | - | -1 | -100.00% | - | Jun 30, 2024 |
SELLAS Life Sciences Group's largest sold out institutional shareholder by shares sold is ANSON FUNDS MANAGEMENT LP, sold -4.83M shares, valued at -, as of undefined.
SELLAS Life Sciences Group Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Nuveen New York Municipal Value Fund 2 | 2.93% | 1,000,000 | - | - | Feb 28, 2021 |
| BLACKROCK MUNIYIELD NEW YORK QUALITY FUND, INC. | 1.64% | 11,835,000 | - | - | Jan 31, 2024 |
| BLACKROCK MUNIHOLDINGS NEW YORK QUALITY FUND, INC. | 1.31% | 8,070,000 | - | - | Jan 31, 2024 |
| BLACKROCK MUNIYIELD NEW YORK QUALITY FUND, INC. | 1.11% | 7,995,000 | - | - | Jan 31, 2024 |
| BLACKROCK NEW YORK MUNICIPAL INCOME QUALITY TRUST | 1.00% | 1,500,000 | - | - | Nov 30, 2020 |
| BLACKROCK MUNICIPAL BOND FUND, INC. | 0.83% | 90,000,000 | - | - | Feb 29, 2024 |
| BLACKROCK NEW YORK MUNICIPAL INCOME QUALITY TRUST | 0.66% | 990,000 | - | - | Nov 30, 2020 |
| BLACKROCK NEW YORK MUNICIPAL INCOME TRUST | 0.60% | 2,845,000 | - | - | Jan 31, 2024 |
| NUVEEN NEW YORK MUNICIPAL VALUE FUND | 0.59% | 1,000,000 | - | - | Feb 29, 2024 |
| BNY MELLON NEW YORK AMT-FREE MUNICIPAL BOND FUND | 0.43% | 1,000,000 | - | - | Aug 31, 2023 |
| BLACKROCK NEW YORK MUNICIPAL INCOME TRUST | 0.42% | 1,995,000 | - | - | Jan 31, 2024 |
| BLACKROCK NEW YORK MUNICIPAL BOND TRUST | 0.34% | 255,000 | - | - | Aug 31, 2020 |
| BLACKROCK MUNICIPAL INCOME FUND, INC. | 0.33% | 5,010,000 | - | - | Jan 31, 2024 |
| BLACKROCK NEW YORK MUNICIPAL INCOME TRUST II | 0.28% | 350,000 | - | - | Nov 30, 2020 |
| BLACKROCK MUNIHOLDINGS NEW YORK QUALITY FUND, INC. | 0.27% | 1,680,000 | - | - | Jan 31, 2024 |
| T. Rowe Price Tax-Free Short-Intermediate Fund, Inc. | 0.22% | 3,310,000 | - | - | Feb 29, 2024 |
| VANGUARD NEW YORK TAX-FREE FUNDS | 0.21% | 10,000,000 | - | - | Feb 29, 2024 |
| BLACKROCK NEW YORK MUNICIPAL INCOME TRUST II | 0.20% | 255,000 | - | - | Nov 30, 2020 |
| T. Rowe Price Tax-Free Short-Intermediate Fund, Inc. | 0.13% | 2,000,000 | - | - | Feb 29, 2024 |
| WILMINGTON FUNDS | 0.13% | 1,500,000 | - | - | Jan 31, 2024 |
| BLACKROCK MULTI STATE MUNICIPAL SERIES TRUST | 0.13% | 2,715,000 | - | - | Feb 29, 2024 |
| SCHWAB INVESTMENTS | 0.09% | 5,330,000 | - | - | Feb 29, 2024 |
| BLACKROCK MULTI STATE MUNICIPAL SERIES TRUST | 0.07% | 1,440,000 | - | - | Feb 29, 2024 |
| EATON VANCE MUNICIPALS TRUST | 0.06% | 5,000,000 | - | - | Jan 31, 2024 |
| BLACKROCK MULTI STATE MUNICIPAL SERIES TRUST | 0.06% | 1,245,000 | - | - | Feb 29, 2024 |
| VANGUARD NEW YORK TAX-FREE FUNDS | 0.06% | 2,815,000 | - | - | Feb 29, 2024 |
| MANNING & NAPIER FUND, INC. | 0.05% | 2,500,000 | - | - | Jan 31, 2024 |
| Hartford Funds Exchange-Traded Trust | 0.04% | 2,300,000 | - | - | Jan 31, 2024 |
| OLD WESTBURY FUNDS INC | 0.04% | 5,150,000 | - | - | Jan 31, 2024 |
| GLENMEDE FUND INC | 0.04% | 335,000 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.03% | 14,905 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.02% | 5,875,000 | - | - | Jan 31, 2024 |
| PIMCO ETF Trust | 0.02% | 5,500,000 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.02% | 2,500,000 | - | - | Mar 28, 2024 |
| NORTHERN FUNDS | 0.02% | 2,500,000 | - | - | Mar 28, 2024 |
| BNY MELLON FUNDS TRUST | 0.01% | 1,060,000 | - | - | Aug 31, 2023 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 42,916 | - | - | Feb 29, 2024 |
| BNY MELLON FUNDS TRUST | 0.01% | 1,000,000 | - | - | Aug 31, 2023 |
| MANNING & NAPIER FUND, INC. | 0.01% | 520,000 | - | - | Jan 31, 2024 |
| SEI TAX EXEMPT TRUST | 0.01% | 475,000 | - | - | Feb 29, 2024 |
| VANGUARD MUNICIPAL BOND FUNDS | 0.01% | 7,095,000 | - | - | Jan 31, 2024 |
| VANGUARD MUNICIPAL BOND FUNDS | 0.01% | 6,160,000 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.01% | 1,000,000 | - | - | Mar 28, 2024 |
| NORTHERN FUNDS | 0.01% | 1,000,000 | - | - | Mar 28, 2024 |
| Brinker Capital Destinations Trust | 0.01% | 400,000 | - | - | Feb 29, 2024 |
| VANGUARD MUNICIPAL BOND FUNDS | 0.01% | 4,660,000 | - | - | Jan 31, 2024 |
| GOLDMAN SACHS TRUST | 0.01% | 20,035,000 | - | - | Mar 31, 2024 |
| OLD WESTBURY FUNDS INC | 0.00% | 650,000 | - | - | Jan 31, 2024 |
| AIM TAX-EXEMPT FUNDS (INVESCO TAX-EXEMPT FUNDS) | 0.00% | 2,780,000 | - | - | Feb 29, 2024 |
| TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 1,490,000 | - | - | Feb 29, 2024 |
| JPMORGAN TRUST II | 0.00% | 4,800,000 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 1,000,000 | - | - | Feb 29, 2024 |
| VANGUARD MUNICIPAL BOND FUNDS | 0.00% | 3,155,000 | - | - | Jan 31, 2024 |
| JPMorgan Trust I | 0.00% | 5,000,000 | - | - | Jan 31, 2024 |
| OLD WESTBURY FUNDS INC | 0.00% | 475,000 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,491,944 | 38,141 | 2.62% | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 500,000 | - | - | Mar 28, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 600,000 | - | - | Feb 29, 2024 |
| EATON VANCE MUNICIPALS TRUST | 0.00% | 200,000 | - | - | Jan 31, 2024 |
| VANGUARD MUNICIPAL BOND FUNDS | 0.00% | 1,590,000 | - | - | Jan 31, 2024 |
| JPMorgan Trust I | 0.00% | 2,500,000 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 440,000 | - | - | Feb 29, 2024 |
| JPMorgan Trust I | 0.00% | 1,890,000 | - | - | Jan 31, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 330,000 | - | - | Feb 29, 2024 |
| VANGUARD NEW YORK TAX-FREE FUNDS | 0.00% | 65,000 | - | - | Feb 29, 2024 |
| VANGUARD MUNICIPAL BOND FUNDS | 0.00% | 1,045,000 | - | - | Jan 31, 2024 |
| VANGUARD MUNICIPAL BOND FUNDS | 0.00% | 1,000,000 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 245,865 | 12,947 | 5.56% | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 1,185,000 | - | - | Jan 31, 2024 |
| iSHARES TRUST | 0.00% | 17,045,000 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 375,000 | - | - | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 17,100 | - | - | Feb 29, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 290,000 | - | - | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 11,110,000 | - | - | Feb 29, 2024 |
| TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 195,000 | - | - | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 8,470,000 | - | - | Feb 29, 2024 |
| THORNBURG INVESTMENT TRUST | 0.00% | 1,000,000 | - | - | Mar 31, 2024 |
| THORNBURG INVESTMENT TRUST | 0.00% | 1,000,000 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 14,948 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 55,000 | - | - | Feb 29, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 265,000 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 100,000 | - | - | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 50,000 | - | - | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 7,255,000 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 16,238 | - | - | Jan 31, 2024 |
| GOLDMAN SACHS TRUST | 0.00% | 1,365,000 | - | - | Mar 31, 2024 |
| HARTFORD MUTUAL FUNDS INC/CT | 0.00% | 2,500,000 | - | - | Jan 31, 2024 |
| HARTFORD MUTUAL FUNDS INC/CT | 0.00% | 2,465,000 | - | - | Jan 31, 2024 |
| VANGUARD NEW YORK TAX-FREE FUNDS | 0.00% | 10,000 | - | - | Feb 29, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 20,000 | -40,000 | -66.67% | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 2,510,000 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 1,000,000 | - | - | Mar 31, 2024 |
| THORNBURG INVESTMENT TRUST | 0.00% | 250,000 | - | - | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 11,400 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 20,000 | - | - | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 10,000 | - | - | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 1,385,000 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 1,320,000 | -1,890,000 | -58.88% | Feb 29, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 30,000 | - | - | Feb 29, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 265,000 | - | - | Mar 31, 2024 |
SELLAS Life Sciences Group's largest mutual fund holder by % of total assets is "Nuveen New York Municipal Value Fund 2", owning 1.00M shares, compromising 2.93% of its total assets.
SELLAS Life Sciences Group Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 35 | 6.06% |
| 31 Mar, 24 | 33 | - |
| 31 Dec, 23 | 33 | 13.79% |
| 30 Sep, 23 | 29 | 11.54% |
| 30 Jun, 23 | 26 | -3.70% |
| 31 Mar, 23 | 27 | -12.90% |
| 31 Dec, 22 | 31 | - |
| 30 Sep, 22 | 31 | 6.90% |
| 30 Jun, 22 | 29 | -6.45% |
| 31 Mar, 22 | 31 | 6.90% |
| 31 Dec, 21 | 29 | -12.12% |
| 30 Sep, 21 | 33 | -13.16% |
| 30 Jun, 21 | 38 | 5.56% |
| 31 Mar, 21 | 36 | 89.47% |
| 31 Dec, 20 | 19 | 90.00% |
| 30 Sep, 20 | 10 | -16.67% |
| 30 Jun, 20 | 12 | 20.00% |
| 31 Mar, 20 | 10 | -9.09% |
| 31 Dec, 19 | 11 | - |
As of 30 Jun 24, 35 institutions are holding SELLAS Life Sciences Group's shares, representing an increase of 6.06% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 4,057,046 | -47.43% |
| 31 Mar, 24 | 7,717,107 | 121.72% |
| 31 Dec, 23 | 3,480,630 | 27.06% |
| 30 Sep, 23 | 2,739,264 | -11.69% |
| 30 Jun, 23 | 3,101,725 | -35.40% |
| 31 Mar, 23 | 4,801,182 | 154.13% |
| 31 Dec, 22 | 1,889,269 | -13.62% |
| 30 Sep, 22 | 2,187,085 | -26.60% |
| 30 Jun, 22 | 2,979,650 | 77.52% |
| 31 Mar, 22 | 1,678,452 | -1.95% |
| 31 Dec, 21 | 1,711,750 | -6.52% |
| 30 Sep, 21 | 1,831,108 | -3.52% |
| 30 Jun, 21 | 1,897,944 | 22.19% |
| 31 Mar, 21 | 1,553,253 | 67.91% |
| 31 Dec, 20 | 925,077 | 50.01% |
| 30 Sep, 20 | 616,676 | 35.26% |
| 30 Jun, 20 | 455,906 | 9.62% |
| 31 Mar, 20 | 415,895 | 6.62% |
| 31 Dec, 19 | 390,067 | - |
SELLAS Life Sciences Group (SLS) has 4.06M shares outstanding as of 30 Jun 24, down -47.43% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 9.05% | 1.57% |
| 31 Mar, 24 | 24.02% | 15.94% |
| 31 Dec, 23 | 12.28% | 13.15% |
| 30 Sep, 23 | 9.66% | 5.57% |
| 30 Jun, 23 | 13.17% | 3.17% |
| 31 Mar, 23 | 20.39% | 21.49% |
| 31 Dec, 22 | 9.74% | 8.61% |
| 30 Sep, 22 | 10.64% | 4.93% |
| 30 Jun, 22 | 14.69% | 13.18% |
| 31 Mar, 22 | 10.56% | 9.08% |
| 31 Dec, 21 | 10.78% | 8.10% |
| 30 Sep, 21 | 11.54% | 7.47% |
| 30 Jun, 21 | 12.43% | 11.40% |
| 31 Mar, 21 | 10.44% | 8.65% |
| 31 Dec, 20 | 10.99% | 20.48% |
| 30 Sep, 20 | 7.33% | 15.91% |
| 30 Jun, 20 | 6.79% | 15.94% |
| 31 Mar, 20 | 6.52% | 17.43% |
| 31 Dec, 19 | 6.12% | - |
As of 30 Jun 24, SELLAS Life Sciences Group is held by 9.05% institutional shareholders, representing a 1.57% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 24 | 60.00% |
| 31 Mar, 24 | 15 | -25.00% |
| 31 Dec, 23 | 20 | 42.86% |
| 30 Sep, 23 | 14 | 27.27% |
| 30 Jun, 23 | 11 | -8.33% |
| 31 Mar, 23 | 12 | -42.86% |
| 31 Dec, 22 | 21 | 110.00% |
| 30 Sep, 22 | 10 | -41.18% |
| 30 Jun, 22 | 17 | 41.67% |
| 31 Mar, 22 | 12 | 9.09% |
| 31 Dec, 21 | 11 | -38.89% |
| 30 Sep, 21 | 18 | -5.26% |
| 30 Jun, 21 | 19 | -9.52% |
| 31 Mar, 21 | 21 | 50.00% |
| 31 Dec, 20 | 14 | 180.00% |
| 30 Sep, 20 | 5 | -16.67% |
| 30 Jun, 20 | 6 | -14.29% |
| 31 Mar, 20 | 7 | -36.36% |
| 31 Dec, 19 | 11 | - |
24 institutional shareholders have increased their position in SLS stock as of 30 Jun 24 compared to 15 in the previous quarter (a 60.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 2 | -66.67% |
| 31 Mar, 24 | 6 | 20.00% |
| 31 Dec, 23 | 5 | - |
| 30 Sep, 23 | 5 | 25.00% |
| 30 Jun, 23 | 4 | - |
| 31 Mar, 23 | 4 | 33.33% |
| 31 Dec, 22 | 3 | -66.67% |
| 30 Sep, 22 | 9 | 125.00% |
| 30 Jun, 22 | 4 | -50.00% |
| 31 Mar, 22 | 8 | 14.29% |
| 31 Dec, 21 | 7 | 40.00% |
| 30 Sep, 21 | 5 | -16.67% |
| 30 Jun, 21 | 6 | 50.00% |
| 31 Mar, 21 | 4 | 100.00% |
| 31 Dec, 20 | 2 | -33.33% |
| 30 Sep, 20 | 3 | 50.00% |
| 30 Jun, 20 | 2 | 100.00% |
| 31 Mar, 20 | 1 | - |
| 31 Dec, 19 | - | - |
2 institutional shareholders have reduced their position in SLS stock as of 30 Jun 24 compared to 6 in the previous quarter (a -66.67% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 35 | 6.06% | 4,057,046 | -47.43% | 9.05% | 1.57% | 24 | 60.00% | 2 | -66.67% |
| 31 Mar, 24 | 33 | - | 7,717,107 | 121.72% | 24.02% | 15.94% | 15 | -25.00% | 6 | 20.00% |
| 31 Dec, 23 | 33 | 13.79% | 3,480,630 | 27.06% | 12.28% | 13.15% | 20 | 42.86% | 5 | - |
| 30 Sep, 23 | 29 | 11.54% | 2,739,264 | -11.69% | 9.66% | 5.57% | 14 | 27.27% | 5 | 25.00% |
| 30 Jun, 23 | 26 | -3.70% | 3,101,725 | -35.40% | 13.17% | 3.17% | 11 | -8.33% | 4 | - |
| 31 Mar, 23 | 27 | -12.90% | 4,801,182 | 154.13% | 20.39% | 21.49% | 12 | -42.86% | 4 | 33.33% |
| 31 Dec, 22 | 31 | - | 1,889,269 | -13.62% | 9.74% | 8.61% | 21 | 110.00% | 3 | -66.67% |
| 30 Sep, 22 | 31 | 6.90% | 2,187,085 | -26.60% | 10.64% | 4.93% | 10 | -41.18% | 9 | 125.00% |
| 30 Jun, 22 | 29 | -6.45% | 2,979,650 | 77.52% | 14.69% | 13.18% | 17 | 41.67% | 4 | -50.00% |
| 31 Mar, 22 | 31 | 6.90% | 1,678,452 | -1.95% | 10.56% | 9.08% | 12 | 9.09% | 8 | 14.29% |
| 31 Dec, 21 | 29 | -12.12% | 1,711,750 | -6.52% | 10.78% | 8.10% | 11 | -38.89% | 7 | 40.00% |
| 30 Sep, 21 | 33 | -13.16% | 1,831,108 | -3.52% | 11.54% | 7.47% | 18 | -5.26% | 5 | -16.67% |
| 30 Jun, 21 | 38 | 5.56% | 1,897,944 | 22.19% | 12.43% | 11.40% | 19 | -9.52% | 6 | 50.00% |
| 31 Mar, 21 | 36 | 89.47% | 1,553,253 | 67.91% | 10.44% | 8.65% | 21 | 50.00% | 4 | 100.00% |
| 31 Dec, 20 | 19 | 90.00% | 925,077 | 50.01% | 10.99% | 20.48% | 14 | 180.00% | 2 | -33.33% |
| 30 Sep, 20 | 10 | -16.67% | 616,676 | 35.26% | 7.33% | 15.91% | 5 | -16.67% | 3 | 50.00% |
| 30 Jun, 20 | 12 | 20.00% | 455,906 | 9.62% | 6.79% | 15.94% | 6 | -14.29% | 2 | 100.00% |
| 31 Mar, 20 | 10 | -9.09% | 415,895 | 6.62% | 6.52% | 17.43% | 7 | -36.36% | 1 | - |
| 31 Dec, 19 | 11 | - | 390,067 | - | 6.12% | - | 11 | - | - | - |
SELLAS Life Sciences Group Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of SELLAS Life Sciences Group's stock was made by CICIC DRAGAN on Jun 27 2024, selling - shares at - per share (valued at -).
SELLAS Life Sciences Group Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q4 2023 | - | 4 | - |
| Q1 2023 | 18 | - | - |
| Q4 2022 | - | 3 | - |
| Q3 2022 | 1 | 1 | 100.00% |
| Q1 2022 | 15 | 1 | 1500.00% |
| Q4 2021 | - | 3 | - |
| Q1 2021 | 10 | - | - |
| Q1 2020 | 10 | - | - |
| Q1 2019 | 9 | - | - |
| Q4 2018 | - | 3 | - |
| Q3 2018 | - | 1 | - |
| Q2 2018 | 7 | 1 | 700.00% |
| Q1 2018 | 10 | 1 | 1000.00% |
| Q4 2017 | 17 | 8 | 212.50% |
| Q3 2017 | 7 | - | - |
| Q2 2017 | 13 | 1 | 1300.00% |
| Q1 2017 | 10 | 1 | 1000.00% |
| Q4 2016 | 1 | - | - |
| Q3 2016 | 10 | - | - |
| Q2 2016 | 1 | 1 | 100.00% |
0 total buy trades, and 4 total sell trades (buy/sell ratio of 0.00%) were made by SELLAS Life Sciences Group's insiders, as of Q4 2023.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q4 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | 3 | - |
| Q3 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | 3 | - |
| Q1 2021 | - | - | - |
| Q1 2020 | - | - | - |
| Q1 2019 | - | - | - |
| Q4 2018 | - | 1 | - |
| Q3 2018 | - | - | - |
| Q2 2018 | - | - | - |
| Q1 2018 | - | - | - |
| Q4 2017 | - | - | - |
| Q3 2017 | - | - | - |
| Q2 2017 | - | 1 | - |
| Q1 2017 | 1 | 1 | 100.00% |
| Q4 2016 | - | - | - |
| Q3 2016 | - | - | - |
| Q2 2016 | - | - | - |
As of Q4 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of SELLAS Life Sciences Group's stocks.
SELLAS Life Sciences Group Peer Ownership
| Ticker | Company |
|---|---|
| MREO | Mereo BioPharma Group plc |
| NLSP | NLS Pharmaceutics AG |
| EYPT | EyePoint Pharmaceuticals, Inc. |
| RVPH | Reviva Pharmaceuticals Holdings, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| OCUP | Ocuphire Pharma, Inc. |
| MCRB | Seres Therapeutics, Inc. |
| RNAZ | TransCode Therapeutics, Inc. |
| AXSM | Axsome Therapeutics, Inc. |
| EFTR | eFFECTOR Therapeutics, Inc. |
| KOD | Kodiak Sciences Inc. |
| IMMX | Immix Biopharma, Inc. |
| EYEN | Eyenovia, Inc. |
| SAVA | Cassava Sciences, Inc. |
| CGTX | Cognition Therapeutics, Inc. |
| ANVS | Annovis Bio, Inc. |
| ZURA | Zura Bio Limited |
| ELEV | Elevation Oncology, Inc. |
| ENVB | Enveric Biosciences, Inc. |
SLS Ownership FAQ
Who Owns SELLAS Life Sciences Group?
SELLAS Life Sciences Group is owned by institutional shareholders (9.05%), insiders (0.24%), and public (90.70%). The largest institutional shareholder of SELLAS Life Sciences Group is VANGUARD GROUP INC (3.99% of total shares) and the top mutual fund owner is Nuveen New York Municipal Value Fund 2 (2.93% of total shares).
Who are the major institutional shareholders of SELLAS Life Sciences Group?
SELLAS Life Sciences Group's major institutional shareholders are VANGUARD GROUP INC, ALYESKA INVESTMENT GROUP, L.P., GEODE CAPITAL MANAGEMENT, LLC, BLACKROCK INC., and OPUS CAPITAL GROUP, LLC. The top five shareholders own together 9.89% of the company's share outstanding.
How many SELLAS Life Sciences Group shareholders are there?
As of Jun 2024, there are 35 institutional shareholders of SELLAS Life Sciences Group.
What percentage of SELLAS Life Sciences Group is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC owns 1.79M shares of SELLAS Life Sciences Group, representing 3.99% of the company's total shares outstanding, valued at $2.13M (as of Jun 2024).
What percentage of SELLAS Life Sciences Group is owned by ALYESKA INVESTMENT GROUP, L.P?
As of Jun 2024, ALYESKA INVESTMENT GROUP, L.P holds 1.48M shares of SELLAS Life Sciences Group (SLS), compromising 3.30% of the company, valued at $1.76M.
What percentage of SELLAS Life Sciences Group is owned by GEODE CAPITAL MANAGEMENT, LLC?
GEODE CAPITAL MANAGEMENT, LLC is the third largest holder of SELLAS Life Sciences Group. The company owns 517.01K of the company's shares outstanding (worth $615.33K).